Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Treasury Shares (2016 - 2025)

Anaptysbio (ANAB) has disclosed Treasury Shares for 5 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares rose 180.54% year-over-year to $3.4 million, compared with a TTM value of $3.4 million through Dec 2025, up 180.54%, and an annual FY2025 reading of $3.4 million, up 180.54% over the prior year.
  • Treasury Shares was $3.4 million for Q4 2025 at Anaptysbio, up from $490228.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $3.4 million in Q4 2025 and bottomed at $292898.0 in Q1 2025.
  • Average Treasury Shares over 4 years is $1.5 million, with a median of $1.4 million recorded in 2023.
  • The sharpest move saw Treasury Shares skyrocketed 297.21% in 2024, then plummeted 86.21% in 2025.
  • Year by year, Treasury Shares stood at $1.0 million in 2022, then skyrocketed by 106.47% to $2.1 million in 2023, then tumbled by 42.21% to $1.2 million in 2024, then surged by 180.54% to $3.4 million in 2025.
  • Business Quant data shows Treasury Shares for ANAB at $3.4 million in Q4 2025, $490228.0 in Q3 2025, and $2.6 million in Q2 2025.